Drug Showcase

OPDIVO (nivolumab)

For metastatic squamous non-small cell lung cancer (NSCLC).

IRESSA (gefitinib)

For metastatic EGFR mutation-positive non-small cell lung cancer (NSCLC).

ELITEK (rasburicase)

For initial management of plasma uric acid levels.

MOZOBIL (plerixafor)

For non-Hodgkin's lymphoma and multiple myeloma.

FARYDAK (panobinostat)

For relapsed multiple myeloma.

CTA Community Poll

Discussing Obesity with Patients With Cancer

We asked readers to weigh in on how they handle the topic of obesity with their patients and the results were surprising.

Physician Communication and Patient Comprehension of Palliative Care

We asked our readers about their experience in dealing with issues surrounding the discussion of palliative care with their patients.

How Do Your Oncology News-Reading Habits Compare to Your Peers?

We asked readers how often they read oncology news and journal articles and what their most trusted sources were.

How Does Your Work Life Balance Compare to Your Peers?

We asked our readers about their work/life balance as it relates to their oncology-related careers.

Condition/Disease-Based Slideshows

Notable Electronic Health Record Milestones

Although there's still a long road ahead in terms of achieving meaningful use incentives, this slideshow explores the history of EHR devices.

Radiation Therapy

This slideshow reviews the uses, benefits, types, side effects, and toxicities associated with radiation therapy.

Pancreatic Cancer

There are several known adverse events associated with the disease and its treatment, including venous thrombosis, pain, and malignant biliary obstruction.

Cancer Cachexia

Patients present with anorexia and a loss of skeletal muscle mass and adipose tissue, with treatment goals revolving around restoring muscle mass and body weight, while preventing further loss.

Complementary and Alternative Medicine in Cancer

CAM is used as an adjunct to traditional therapies in an effort to provide supportive care in improving symptom control and patient well-being.


Gliomas are the most common form of brain tumors, which begin in the glial (supportive) tissue.

14 Chemotherapy-Related Adverse Effects

Patients receiving treatment for cancer can experience a number of potential side effects and reactions.

Chemotherapy Induced Alopecia (CIA)

Compared to the severe adverse effects of chemotherapy, chemotherapy-induced alopecia (CIA) is surprisingly one of the more troubling aspects.

Managing Neutropenia in a Patient with Abdominal Pain Following Chemotherapy

MP is a 38-year-old woman who comes to the clinic with a temperature of 101F and complains of abdominal pain approximately 14 days after her last chemotherapy treatment.

Colorectal Cancer

Colorectal cancer is the 3rd most common cancer, and the 2nd most common cause of death in the United States.


Retinoblastoma is a rare cancer that is caused by a mutation in the retinoblastoma gene (RB1) controlling cell division of the retina.

Ewing Sarcoma

Ewing sarcoma is one of a group of cancers known collectively as the Ewing sarcoma family of tumors.

Breast Cancer

Breast cancer is the most commonly diagnosed cancer among women in the U.S. besides skin cancer.

Lung Cancer

More people in the United States die from lung cancer than any other type of cancer. This is true for both men and women.


Melanoma is the most dangerous type of skin cancer, and the most deadly.

Chemotherapy-Related Skin Toxicities

The incidence of cancer diagnoses is increasing worldwide as the world’s population grows and people continue to live longer.

Oral Mucositis

More than 40% of patients undergoing chemotherapy develop some degree of mucositis during the course of their treatment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs